|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:1608-1615
© 2004 The American Association for Thoracic Surgery
Surgery for acquired cardiovascular disease |
a Department of Cardiovascular Surgery, the Graduate School of Medicine, Kyoto University, Kyoto, Japan
b Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
c Hayama Heart Center, Kanagawa, Japan
Read at the Eighty-third Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 4-7, 2003.
Received for publication May 19, 2003; revisions received August 8, 2003; revisions received August 11, 2003; accepted for publication September 17, 2003.
* Address for reprints: Masashi Komeda, MD, PhD, Professor of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin, Sakyo-Ku, Kyoto, Japan PO: 606-8507
masakom{at}kuhp.kyoto-u.ac.jp
OBJECTIVE: We have developed a technique for biologic coronary artery bypass grafting, which is a revival of a classic concept with modern biotechnology.
METHODS: Acute myocardial infarction was created by ligating the major branch of the circumflex artery in rabbits. Animals were divided into four groups: a nontreated group (group N), a group in which omentum was used to wrap the infarcted area (group G), a group in which a gelatin hydrogel sheet incorporating 100 µg basic fibroblast growth factor was placed over the infarcted area (group F), and a group in which the infarcted area was similarly treated with basic fibroblast growth factor followed by omental wrapping (group FG). Cardiac function was subsequently assessed by echocardiography. Postmortem angiography through the gastroepiploic artery was done in groups G and FG. Infarct size and arteriolar density were evaluated.
RESULTS: Group FG showed a better fractional area change than did the other groups (group N P < .001, group G P = .002, group F P < .001). Angiography revealed that communication from the gastroepiploic artery to the coronary artery was created through a rich bed of neovascularization in all 7 animals of group FG, whereas poor collaterals were recognized in only 2 of 7 animals in group G. Infarct size was reduced to a greater extent in group FG than in groups F, G, and N (10% ± 3%, 16% ± 5%, 19% ± 7%, 23% ± 2%, respectively, group F P = .04, groups G and N P < .01). The number of arterioles 20 to 100 µm in diameter was increased to a greater extent in group FG than in groups F, G, and N (23 ± 5 arterioles/mm2, 14 ± 3 arterioles/mm2, 10 ± 1 arterioles/mm2, 4 ± 2 arterioles/mm2, respectively), with the differences being significant.
CONCLUSIONS: These results show that bypass from the gastroepiploic artery to coronary arteries can be achieved without surgical anastomosis through slow release of basic fibroblast growth factor in this rabbit acute myocardial infarction model. This new revascularization concept, biologic coronary artery bypass grafting, could be applicable for revascularizing many tiny coronary vessels in patients who are difficult to treat with conventional surgery or catheter intervention.
This article has been cited by other articles:
![]() |
M. Komeda, A. Marui, K. Tambara, M. Yamamoto, Y. Saji, T. Nishina, and Y. Tabata Biologic anastomosis: The first case of biologic coronary bypass surgery J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 775 - 777. [Full Text] [PDF] |
||||
![]() |
T. Dvir, A. Kedem, E. Ruvinov, O. Levy, I. Freeman, N. Landa, R. Holbova, M. S. Feinberg, S. Dror, Y. Etzion, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome PNAS, September 1, 2009; 106(35): 14990 - 14995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirose, A. Marui, Y. Arai, T. Kushibiki, Y. Kimura, H. Sakaguchi, H. Yuang, B.I.R. S. Chandra, T. Ikeda, S. Amano, et al. Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1250 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, Y. Nitta, Y. Saiki, S. Kawamoto, A. Iguchi, M. Kaku, Y. Tabata, and K. Tabayashi Enhanced Perigraft Angiogenesis Prevents Prosthetic Graft Infection Ann. Thorac. Surg., October 1, 2008; 86(4): 1278 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takaba, C. Jiang, S. Nemoto, Y. Saji, T. Ikeda, S. Urayama, T. Azuma, A. Hokugo, S. Tsutsumi, Y. Tabata, et al. A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: Evolving concept of biologic coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 891 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kanamori, G. Watanabe, T. Yasuda, H. Nagamine, H. Kamiya, and Y. Koshida Hybrid Surgical Angiogenesis: Omentopexy Can Enhance Myocardial Angiogenesis Induced by Cell Therapy Ann. Thorac. Surg., January 1, 2006; 81(1): 160 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirose, A. Marui, Y. Arai, M. Fujita, T. Nomura, M. Mitsuyama, Y. Tabata, and M. Komeda Sustained-release form of basic fibroblast growth factor prevents catheter-related bacterial invasion in mice Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 526 - 530. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |